Insulet and GlaxoSmithKline to Bring the OmniPod to Canada
GlaxoSmithKline is partnering with Insulet to make the OmniPod available in Canada for the first time. Under the new partnership, Insulet will continue to manufacture the OmniPod while GlaxoSmithKline will handle all other business aspects involved in getting the product to Canadian customers. The wireless pump is already approved by the regulatory authorities in Canada, and GlaxoSmithKline has begun to sell it. We have sung the praises of the OmniPod previously (see our Test Drive in diaTribe #4), and we are glad to see this technology made available in more countries. Looking to the future, GlaxoSmithKline also plans to make the second-generation OmniPod available in Canada once it has received regulatory approval, which Insulet hopes will be achieved in the next year. The new pod will be a third smaller and 25% lighter. –ST